Skip to main content
EYPT
NASDAQ Industrial Applications And Services

EyePoint Hit With Securities Class Action Over DURAVYU Disclosures

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.282
Mkt Cap
$30.061M
52W Low
$0.264
52W High
$19.11
52W Position info
6.8% above low
Off High info
99% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

EYPT is trading near its 52-week low of $0.264 (6.8% above the low).

Summary

EyePoint disclosed a securities class action filed November 17, 2026 alleging false and misleading statements about DURAVYU during May 2025–August 2026; damages are unspecified and the company denies the claims.


Key Events · Legal and Risk Events · EYPT

  • Securities Class Action Filed

    Marco Kälin v. EyePoint, Inc., Civil Action No. 1:26-cv-07418, was filed November 17, 2026 in the U.S. District Court for the Eastern District of New York against the company and its executive officers.

  • Claims Target DURAVYU Disclosures

    The complaint alleges violations of Sections 10(b)/20(a) and Rule 10b-5 over purportedly false and misleading statements about lead candidate DURAVYU during the class period May 27, 2025 to August 14, 2026.

  • Damages Unspecified

    The suit seeks unspecified damages plus attorneys' fees, expert fees and costs; with no dollar amount or reserve disclosed, exposure cannot be sized from this filing.

  • Company Denies Allegations

    EyePoint states that the allegations lack merit and that it intends to vigorously defend the action.


Analysis · EYPT · Industrial Applications And Services

A putative class action filed November 17, 2026 alleges that EyePoint and its executive officers made false and misleading statements about DURAVYU between May 27, 2025 and August 14, 2026 — the window covering the program's Phase 3 setbacks. Damages are unspecified, so the size of any exposure is unknown, but the suit lands on a company already in a fragile state: the Q3 10-Q disclosed substantial doubt about its ability to continue as a going concern, and the stock trades at $0.28. Defense costs and management distraction compound an already thin cash position, and any settlement or judgment would rank alongside the company's other obligations. EyePoint says the claims lack merit and will defend vigorously.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, EYPT was trading at $0.28 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $30.1M. The 52-week trading range was $0.26 to $19.11. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EYPT - Latest Insights

EYPT
Nov 12, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.350
Real-time Price: $0.2454 info
Change: -$0.1046 (-30%) info
Market Cap: $27.706M info
EYPT
Nov 12, 2026, 7:05 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.360
Real-time Price: $0.2454 info
Change: -$0.1146 (-32%) info
Market Cap: $27.706M info
EYPT
Nov 12, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.360
Real-time Price: $0.2454 info
Change: -$0.1146 (-32%) info
Market Cap: $27.706M info
EYPT
Oct 19, 2026, 9:22 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.5443
Real-time Price: $0.2454 info
Change: -$0.2989 (-55%) info
Market Cap: $27.706M info
EYPT
Oct 19, 2026, 8:08 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.6115
Real-time Price: $0.2454 info
Change: -$0.3661 (-60%) info
Market Cap: $27.706M info